Sens. Marco Rubio, R-Fla., and Elizabeth Warren, D-Mass., introduced the bill. If passed, the bill would require the Federal Trade Commission and the Treasury secretary to conduct research on the U.S. drug manufacturing industry. The senators argue the COVID-19 pandemic has exposed the U.S.’ dependence on drugs made in China and other countries.
“To defeat the current COVID-19 crisis and better equip the United States against future pandemics, we must take control of our supply chain and rely less on foreign countries for our critical drugs,” Ms. Warren said.
Mr. Rubio told The Hill that the bill would provide lawmakers the information they need to address inefficiencies in the U.S. drug supply chain.
Peter Navarro, President Donald Trump’s economic advisor, had pledged in April that the U.S. would move away from its reliance on foreign countries for drugs and medical supplies, The Hill reported.
Read the full article here.
More articles on pharmacy:
Pfizer sues HHS over Medicare rules
Prices of 245 drugs hiked in 6 months
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.